Purpose. The aim of study was to normalize the intraocular pressure for maintenance of residual visual functions of the patient operated for glaucoma secondary to active tubercular uveitis. Material and methods. A 53-year-old man suffers from tubercular-allergic uveitis during more than 10 years, glaucoma was diagnosed since 2001. The previous surgical methods of treatment (laser trabeculoplasty, sinus trabeculectomy (STE) with basal iridectomy) were ineffective. During medicamentous therapy the intraocular pressure increased up to 28-32 mmHg. Visual acuity is 0.03, not corrected. Patient was treated with antituberculosis therapy consisted of three medicines (Phthivazidum 1.0; Pyrazinamide 1.5; Avelox 0.4). Patient underwent sinus trabeculectomy with a partial iridectomy and implantation of biodegradable drainage implant “Glautex” of High Be Tech Ltd. production (Register certificate FSR 2012/13098). Results. There were no complications during postoperative period. Intraocular pressure remained stable (17-19 mmHg by Maklakov) without ocular hypotensive therapy. There were no signs of recurrent uveitis, visual acuity was 0.03, not corrected. Conclusions. The biodegradable drainage implant “Glautex” can be inserted to patients with glaucoma secondary to active tubercular uveitis owing to its high biocompatibility with the cellular structures of human tissues and controlled bio-absorbable properties.